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METHODOLOGY
Comparison of two different culture conditions for derivation of
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Abstract
Different culture-systems for derivation of induced pluripotent stem cells (iPSC) in vitro from human ﬁbroblasts have been
established. Here, we compared the efﬁcacy of two different feeder-free culture-systems; Matrigel-coated surfaces in
combination with mTeSR1 medium versus Vitronectin-coated surfaces in combination with Essential 8 (E8) medium. The
comparison was performed by counting the number of emerging iPSC-looking colonies of re-programmed ﬁbroblasts. The
ﬁbroblasts were re-programmed using episomal plasmids expressing OCT3/4, SOX2, KLF4, L-MYC, LIN28, and a p53 knock
down shP53. Three different ﬁbroblast lines, K40 and K48 from healthy controls and BBS1 from a patient with Bardet–Biedl
syndrome, were used in two independent setups. The BBS1 line was used in both setups in combination with K40 and K48
respectively. In all four re-programming experiments, we observed a signiﬁcantly higher number of emerging colonies with
the combination Matrigel/mTeSR1 as compared to the combination Vitronectin/E8. The presence of iPSC was veriﬁed by
alkaline phosphatase and Tra-1-60 staining. Furthermore, a higher expression of the pluripotency-associated markers
NANOG and SOX2 in cells under Matrigel/mTeSR1 conditions compared with Vitronectin/E8 supported the higher
proportion of iPSC on Matrigel/mTeSR1 plates. In conclusion, the combination Matrigel/mTeSR1 is more efﬁcient for
derivation of iPSC compared to the Vitronectin/E8 combination.
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Background
The discovery of pluripotent stem cells in 1981 by Evans and
Kaufman were thought to initiate a revolution in research
and the treatment of diseases (Evans and Kaufman, 1981).
They demonstrated that cells from the inner cell mass of
mouse blastocysts were undifferentiated, and capable of
developing into cells of all three germ layers; endoderm,
mesoderm, and ectoderm (Evans and Kaufman, 1981;
Martin, 1981). The use of embryos to obtain these cells
however raised ethical concerns. This problem was recently
resolved by the groundbreaking discovery of the ability to
induce a new type of pluripotent stem cell from somatic cells;
Takahashi and Yamanaka discovered in 2006 that mouse
(Takahashi and Yamanaka, 2006) and in 2007 (Takahashi
et al., 2007) human ﬁbroblast cells could be re-programmed
into a pluripotent state by adding factors essential to
embryonic development (Takahashi and Yamanaka, 2006;
Takahashi et al., 2007). After identifying 24 genes encoding
pluripotency-inducing factors, they found only two of these
to be essential for the re-programming process, and two to
be dispensable but increasing the re-programming efﬁciency
markedly (Takahashi and Yamanaka, 2006). This new type
of stem cell is known as induced pluripotent stem cells
(iPSC), and the factors they used are known as the “OSKM”
factors; OCT3/4, SOX2, KLF4, and C-MYC (Takahashi and
Yamanaka, 2006; Takahashi et al., 2007). In 2007 another
group also succeeded in generating human iPSC using
OCT4, SOX2, NANOG, and LIN28 (Yu et al., 2007).
Successful generation of human iPSC subsequently allowed
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researchers to create disease-speciﬁc model systems and
patient-speciﬁc iPSC, bringing cell therapy one step closer to
reality (Rodrıguez-Piza et al., 2010). Since the discovery of
iPSC, focus has been directed towards optimizing re-
programming efﬁciency and derivation of pluripotent stem
cells (iPSC). This has been achieved by investigating
additional re-programming factors (Yu et al., 2007; Yu
et al., 2009) and how these factors are delivered to the cells as
well as the chosen culture system. Optimizations used today
include a brief suppression of p53 by adding a short hairpin
RNA against p53 (shP53) (Hong et al., 2009; Rasmussen
et al., 2014) and using L–MYC instead of C-MYC to increase
the re-programming efﬁciency and to decrease the risk of
tumorigenesis (Okita et al., 2011).
There are several systems for the delivery of re-
programming factors. Episomal plasmids are widely used
today (Yu et al., 2009; Okita et al., 2011; Rasmussen et al.,
2014). This technique is based on the Epstein-Barr Nuclear
Antigen-1 (oirP/EBNA-1) system that has been proven to
generate iPSC without any transgenic sequences integrating
into the target cell genome (Yu et al., 2009). The oriP/EBNA-
1 system replicates only once per cell cycle and has been
reported to be lost over time without drug selection (Yates
and Guan, 1991; Yu et al., 2009).
Murine feeder cells and conditioned media were
previously used routinely to support cell growth and
maintain the pluripotency of embryonic stem cells (ESC)
and iPSC. However, culture conditions have since been
optimized and simpliﬁed to achieve a more standardized
and reproducible result. Today, mTeSR1 and Essential 8
(E8), both based on DMEM-F12, are the two widely used
stem cell-supporting media. The mTeSR1 medium is
serum-free, but does not have a completely deﬁned
formulation because it contains bovine serum albumin
(BSA) (Ludwig et al., 2006) known to have batch variations
which could affect the outcome. A simpliﬁed version of
mTeSR1 was subsequently developed; the completely
chemically deﬁned E8. These media contain only 8
components, all synthetic, identiﬁed from 16 components
included in mTeSR1 that are required and sufﬁcient for
cell-survival and the prevention of spontaneous differenti-
ation of iPSC (Chen et al., 2011).
Basement matrices have been developed and optimized
for both media types. Matrigel1 matrix (Corning) is a
widely used product, but as it is extracted from Engelbreth-
Holm-Swarm (EHS) mouse sarcoma cells it is not
completely chemically deﬁned (Kleinman et al., 1982;
Kleinman et al., 1986; Bissell et al., 1987; McGuire and
Seeds, 1989; Vukicevic et al., 1992). To circumvent this, a
completely synthetic and simpliﬁed basement matrix
composed of Vitronectin was designed based on the
clariﬁcation of adherence receptors used by human ESC
(Chen et al., 2011). Matrigel matrix is typically used in
combination with mTeSR1 and Vitronectin is typically
used in combination with E8 media, and both conditions
have been shown to sustain iPSC expansion for more than
10 passages (Ludwig et al., 2006; Chen et al., 2011).
Here, we compared the two commonly used feeder-free
culture conditions for derivation of induced pluripotent
stem cells (iPSC) at an early stage after reprogramming;
Matrigel combined with mTeSR1 compared to Vitronectin
combined with E8 (Okita et al., 2011; Rasmussen et al.,
2014). Fibroblasts were reprogrammed using three episomal
plasmids coding for a modiﬁed human version of the OSKM
genes and a short hairpin RNA against p53 (shp53).
Materials and methods
Cell culture
Fibroblast cell cultures were established from skin biopsies.
The ﬁbroblasts were grown in T75 ﬂasks (Sarstedt #2020-06)
using DMEM F–12þGlutaMAX (Gibco #31331-028) with
10% bovine calf serum and 1% pen/strep at 37C in 5% CO2
and passaged with trypsin-EDTA (Gibco #25300-054) when
they reached conﬂuency. Two different ﬁbroblast-lines from
healthy controls, K40 and K48, and one ﬁbroblast-line from
a patient with Bardet–Biedl syndrome, BBS1 were used.
iPSC re-programming
iPSC re-programming of human dermal ﬁbroblasts was
performed as described previously (Okita et al., 2011;
Rasmussen et al., 2014) by electroporation with episomal
plasmids that encode hSOX2 and hKLF4 (addgene plasmid
#27078) hL-MYC and hLIN28 (addgene plasmid #27080)
and hOCT4 with a short hairpin RNA to P53 (shp53)
(addgene plasmid #27077). Each plasmid was used at an
amount of 1.25mg in the ratio 1:1:1. The plasmids were
introduced with Amaxa NucleofectorTM 2b (Lonza) using
the Amaxa Basic Nucleofector Kit for Primary Mammalian
Fibroblasts (Lonza #VPI-1002) following themanufacturer’s
protocol with program V-024;
http://bio.lonza.com/ﬁleadmin/groups/marketing/Down-
loads/Protocols/Generated/Optimized_Protocol_226.pdf.
Seven days after electroporation, the cells were split and
transferred to six well plates (CellStar #657 160) coated with
Corning Matrigel Matrix (Corning #354277) or Vitronectin
XFTM (Stemcell #07180), respectively (6 104cells/well).
The coating was performed according to the manufacturer’s
instructions. The Matrigel-coated wells contained pre-
warmed mTeSR1 (Stemcell #05857) medium while the
Vitronectin-coated wells contained pre-warmed E8medium
(ThermoFischer #A1517001). The media were supple-
mented with 1% pen/strep. The cells were grown in 5%
CO2, 5% O2 in N2 at 37C.
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Staining for alkaline phosphatase
On Day 28 after re-programming, iPSC colonies were
stained for alkaline phosphatase (AP) activity using the iPSC
characterization kit, SAB-KIT-1 (System Biosciences). The
iPSC were ﬁxed for 5min with 4% paraformaldehyde (PFA)
and incubated for 20min in the dark in 500mL of AP stain-
mix composed of the two components “A” and “B” mixed
1:1 according to the manufacturer’s instructions. The cells
were kept in PBS until microscopy.
Staining for Tra-1-60
The cells were ﬁxed for 15min in 4% PFA followed by
washing and incubation in permeabilization buffer (0.2%
TritonX-100, in PBS) for 15min and then in blocking buffer
(3% bovine serum albumin (BSA) (Tocris Bioscience #5217))
diluted in permeabilization buffer for 30min. The cells were
incubated with the primary antibody (Tra-1-60 (System
Biosciences, #SAB-100A-1, 1:100)), diluted in blocking buffer
for 2 h at room temperature. This step was followed by a wash
in blocking buffer and incubation with the secondary
antibodies (ThermoFisher Scientiﬁc, #A10036, 1:800) diluted
in blocking buffer at room temperature for 45min. The cells
were kept in PBS until microscopy.
Quantitative real-time PCR
The cells were harvested using trypsin-EDTA (Gibco #25300-
054), and total RNA was extracted using the Qiagen RNeasy
Mini Kit (#74106) according to the manufacturer’s instruc-
tions. A NanoDrop ND-1000 spectrophotometer was used to
measure the RNA concentrations. The High Capacity cDNA
kit (Applied BioSystems #4368813) was used for the prepara-
tion of cDNA. The cDNA samples were assayed in triplicate in
16.7 ng/sample in a total volume of 25mL. Universal PCR
Master Mix (Applied Biosystems #4318157) and Taqman
probes against SOX2 and NANOG transcripts (SOX2;
hs01053049s1, NANOG; hs04260366g1 from Applied Bio-
systems) both spanning exonswere used.AFAM labeled probe
and primers for the human GAPDH transcript (part number
4352934E) were used as an endogenous control. A relative
quantiﬁcation ofGAPDH transcript was carried out on parallel
samples. PCR ampliﬁcation and detection were performed
with an ABI7500 (Applied Biosystems, www.invitrogen.com)
in accordance with the manufacturer’s instructions. The CT
value is the cycle number at which the ﬂuorescence generated
within a reaction crosses the threshold line. Standard curves for
CT values compared with log cDNA concentration were
prepared by assaying threefold serial dilutions of control
cDNA: from 50ng/sample to 0.62ng/sample. The amount of
transcript was calculated by linear regression of the lines
generated by the standard curves, log cDNA concentration
against CT (http://www3.appliedbiosystems.com/cms/groups/
mcb_support/documents/generaldocuments/cms_042380.
pdf). The normalized SOX2 and NANOG values were
calculated by dividing with the GAPDH value.
Results and discussion
To ascertain that the obtained results were not cell-line
speciﬁc, three different human dermal ﬁbroblast cell lines
were re-programmed. In brief, one primary ﬁbroblast-line,
BBS1 were obtained from a patient suffering from Bardet–
Biedl syndrome, and two ﬁbroblast-lines, K40, and K48 from
two healthy controls. The re-programming was performed in
two independent setups, with the inclusion of BBS1 in both
setups. In one setup, BBS1 in combination with K48 were re-
programmed (Figure 1), whereas BBS1 and K40 were re-
programmed in another setup (Figure S1). The ﬁbroblast-
lineswere re-programmed into iPSCbynucleofectionof three
episomal plasmids, encoding the human genes; OCT3/4,
SOX2, KLF4, L-MYC, LIN28, and a p53 knock down shP53
(5 105 cells of each type per transfection). Six days later, half
of the cells were re-seeded on Matrigel-coated plates
combined with mTeSR1 medium, whereas the other half
were plated on Vitronectin-coated plates combined with E8
(6 104 cells/well) (Figures 1A and S1).
The morphological changes were monitored carefully
during the 28 day course of the experiment. By Day 10–14
after electroporation, stem cell-looking colonies were easily
visible (Figures 1B and S1). The size and morphology of the
colonies on Matrigel/mTeSR1 plates were larger and more
well-deﬁned compared to the colonies that developed on
Vitronectin/E8 plates. This tendency became more pro-
nounced with time, after 22–23 days and 27–28 days,
respectively (Figures 1B and S1). By Day 28, the colonies
formed on Matrigel/mTeSR1 plates had grown large in size
and began to show signs of differentiation in the middle.
Colonies grown onVitronectin/E8 plates also showed signs of
differentiation but did not seem to increase in size to the same
extent, and the overgrowth of surrounding cells continued,
making the stem cell-looking colonies hard to distinguish
from the surrounding ﬁbroblasts or partially reprogrammed
cells. Morphologically, the colonies obtained on theMatrigel/
mTeSR1 plates were round in shape with well-deﬁned edges,
whereas the colonies on the Vitronectin/E8 plates were more
diffuse, embedded in the surrounding cells and generally
appeared to be smaller (Figures 1B and S1). There was no
difference in themorphology or size of the colonieswhichhad
formed from the ﬁbroblast control cell-lines, versus the
colonies formed fromtheBardet–Biedlpatientﬁbroblast-line.
On Day 28, selected colonies from both the patient and
healthy control grown under the two different conditions
were investigated for their expression of the pluripotency
markers alkaline phosphatase and Tra-1-60 (Yu et al., 2007).
All tested presumed stem-cell colonies stained positive for
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alkaline phosphatase (Figures 2A and S2) and Tra-1-60
(Figures 2B and S2). Investigation of the entire wells stained
for alkaline phosphatase activity, conﬁrmed that the colonies
on theMatrigel/mTeSR1 plates were larger than the colonies
on the Vitronectin/E8 plates (Figures 2C and S2). Further-
more, the number of colonies on the Matrigel/mTeSR1
plates was signiﬁcantly higher than the number of colonies
grown under Vitronectin/E8 conditions, regardless of
Day 4
Day 14
Patient (BBS1) Control (K48)
Day 22
Day 28
Fibroblast medium 
mTeSR1 medium / matrigel coang
E8 medium / vitronecn coang
Nucleofection with 
Oct3/4, Sox2, Klf4,     
L-Myc and Lin28 
Day 0 Day 6 Day 28
Splitting onto the two 
tested conditions
Tra-1-60 staining and 
AP staining or 
manual passage
A
B
K48 mg/mTeSR K48 v/E8BBS1 mg/mTeSR BBS1 v/E8
Figure 1 Re-programming setup and observation ofmorphological changes during the course of re-programming. (A) Scheme depicting the
protocol for ﬁbroblast re-programming with the episomal plasmids expressing hOTC4, hSOX2, hKLF4, hL-MYC, hLIN28, and shp53 grown under
Matrigel/mTeSR1 (mg/mTeSR) and Vitronectin/E8 (v/E8) conditions, respectively. (B)Morphology of human ﬁbroblasts and induced pluripotent stem cells
(iPSC) on days 4, 14, 22, and 28 after re-programming and grown under Matrigel/mTeSR1 (mg/mTeSR) or Vitronectin/E8 (v/E8) conditions, respectively.
Arrows indicate forming iPSC colonies. Scale bar 100mm.
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whether the cells were obtained from a healthy control or a
patient with Bardet–Biedl syndrome (Figures 2C and S2).
The number of colonies on the Vitronectin/E8 plates for the
two setups were 36 8 for K40/K48 and 17 11 for BBS1,
whereas the number of colonies on the Matrigel/mTeSR
plates were 56 5 for K40/K48 and 25 10 for BBS1
(Figures 2C and S2). However, because the colonies on the
Vitronectin/E8 plates were very small, the total number of
colonies on these plates might be underestimated.
To monitor the re-programming process, RNA from a
fraction of the cells was harvested on days 0, 6–7, 14, 21, and
28 post electroporation, and analyzed by quantitative real-
time PCR (RT-q-PCR) to see whether expression of the
pluripotency-associated markers NANOG and SOX2
increased during re-programming. Both genes should be
upregulated at the end of re-programming (Buganim et al.,
2012). The expression of NANOG and SOX2 in cells
obtained from both controls and BBS patient grown in the
Matrigel/mTeSR combination had indeed increased from
Day 0, whereas the expression was low/barely detectable in
cells grown under the Vitronectin/E8 condition (Figures 3
and S3). The more robust signal of SOX2 andNANOG in the
cells grown under Matrigel/mTeSR1 conditions compared
with cells grown under Vitronectin/E8 conditions might be
due to a larger proportion of iPSC versus ﬁbroblasts in the
Matrigel/mTeSR1 wells compared with the cells in the
Vitronectin/E8 wells, on which there was a rapid growth of
non-stem cells.
v/E8mg/mTeSR
BBS1
K48
Tra-1-60Tra-1-60
Tra-1-60 Tra-1-60
AP
A
B
K48 mg/mTeSR K48 v/E8BBS1 mg/mTeSR BBS1 v/E8
K48 mg/mTeSR K48 v/E8BBS1 mg/mTeSR BBS1 v/E8
AP
C
Figure 2 Characterization of the iPSC derived from healthy control or patient ﬁbroblasts day 28 after re-programming, grown under
Matrigel/mTeSR1 (mg/mTeSR), or Vitronectin/E8 (v/E8) conditions. (A) Alkaline phosphatase staining of representative iPSC colonies. (B)
Representative iPSC colonies investigated by phase contrast images and immunostained for the pluripotencymarker Tra-1-60 (green). (A and B) Scale bar
100mm. (C) Alkaline Phosphatase (AP) staining (brown) of whole wells. Scale bar 5mm.
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Products that contain animal derivatives, barricade any
effort to achieve good manufacturing practice (GMP)
standards (Lu et al., 2014). Thus the speciﬁc composition
of mTeSR1 and Matrigel differs from batch to batch, which
makes it hard to reproduce experiments precisely. Further-
more, exposure to products of animal origin increases the
risk of transmission of non-human pathogens. Thus,
synthetic products are to be preferred for the generation
of iPSC for clinical applications. Since colonies were formed
on Vitronectin/E8 plates, this completely synthetic condi-
tion supports the growth and formation of iPSC, but must be
optimized in order to obtain the isolation of larger colonies.
Conclusions
In summary, the combination Matrigel/mTeSR is a good
choice for making iPSC for research use. We found that
derivation of early hiPSC of recent re-programmed
ﬁbroblasts resulted in larger and a signiﬁcantly higher
number of iPSC colonies, whenMatrigel was combined with
mTeSR1 as compared to E8 combined with Vitronectin.
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Figure S1. Morphology of human ﬁbroblasts and induced
pluripotent stem cells (iPSC) on days 4, 10, 23, and 27 after re-
programmingwith the episomal plasmids expressing hOTC4,
hSOX2, hKLF4, hl-MYC, hLIN28, and shp53 grown under
Matrigel/mTeSR1 (mg/mTeSR) and Vitronectin/E8 (v/E8)
conditions, respectively. Arrows indicate forming iPSC
colonies. Scale bar 100mm. Patient: BBS1; Control: K40.
Figure S2. Characterization of the iPSC derived from
control or patient ﬁbroblasts, day 28 after re-programming
grown under Matrigel/mTeSR1 (mg/mTeSR) or Vitronec-
tin/E8 (v/E8) conditions. Left: Entire wells stained for
Alkaline phosphatase (AP) (brown). Petri dish diameter is
3.7 cm. Middle: Selected colonies stained for Alkaline
phosphatase (AP) (brown). Right: Selected colonies stained
for Tra-1-60 (green).
Figure S3. Monitoring of NANOG and SOX-2 expression
during the course of re-programming. Samples are normal-
ized to GAPDH expression. Error bars represent the
standard deviation. Patient: BBS1; Control: K40.
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